CVS Health plans to split into two publicly traded companies by the first half of 2028. The company said it would separate its pharmacy business, including roughly 9,000 retail locations, from its insurance business and its pharmacy benefit manager, Caremark.
CVS considered a breakup more than two years ago but did not proceed. Brian Tanquilut, a senior equity research analyst at Jefferies, told CNBC that at the time, "the idea of retail standing alone was unthinkable."
According to the report, the economics have since changed. CVS's retail pharmacy business has become more consistently profitable, and its insurer, Aetna, has improved its performance despite high medical costs in Medicare Advantage plans. Michael Cherny, a senior research analyst at Leerink Partners, said the pharmacy "is a much different business" than it was in prior years.
CVS CEO David Joyner told CNBC that in 2024 the company was "in a turnaround" without the flexibility or cash to execute a split. He told analysts the decision comes "out of strength." The company has posted eight consecutive quarters of beating Wall Street earnings estimates, and it expects at least $15.5 billion in operating cash flow in 2026, up from $9.1 billion in 2024.
The report says retail pharmacy remains low-margin, with adjusted operating margins of roughly 4% to 5%. Analysts quoted in the report say it may now be stable enough to operate independently, though investors may value it at a discount. RBC Capital Markets analyst Ben Hendrix wrote that this lower valuation has weighed on CVS's overall value.
Shares dropped about 12% on the announcement, according to the report. Joyner told the Wall Street Journal that regulatory issues were not the reason for the split. The report also notes that Tennessee and Arkansas have passed laws that would bar one company from owning both a pharmacy and a PBM, and that the Arkansas measure has been held up in court.